N. J. Gannon

Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigs

BACKGROUND Recent studies suggest that resistant starch (effective in producing butyrate and lowering possibly toxic ammonia) is rapidly fermented in the proximal colon; the distal colon especially would, however, benefit from these properties of resistant starch. AIMS To determine whether wheat bran (a rich source of insoluble non-starch polysaccharides), known to hasten gastrointestinal transit, could carry resistant starch through to the distal colon and thus shift its site of fermentation. METHODS Twenty four pigs were fed four human type diets: a control diet, or control diet supplemented with resistant starch, wheat bran, or both. Intestinal contents and faeces were collected after two weeks. RESULTS Without wheat bran, resistant starch was rapidly fermented in the caecum and proximal colon. Supplementation with wheat bran inhibited the caecal fermentation of resistant starch, resulting in an almost twofold increase (from 12.9 (2.5) to 20.5 (2.1) g/day, p<0.05) in resistant starch being fermented between the proximal colon and faeces. This resulted in higher butyrate (133%, p<0.05) and lower ammonia (81%, p<0.05) concentrations in the distal colonic regions. CONCLUSIONS Wheat bran can shift the fermentation of resistant starch further distally, thereby improving the luminal conditions in the distal colonic regions where tumours most commonly occur. Therefore, the combined consumption of resistant starch and insoluble non-starch polysaccharides may contribute to the dietary modulation of colon cancer risk.

Ractopamine hydrochloride improves growth performance and carcass composition in immunocastrated boars, intact boars, and gilts

The beta-agonist ractopamine is a dietary ingredient that improves growth and increases the lean mass with little change in fat mass in gilts and barrows. Limited data in boars indicate that dietary ractopamine may increase lean tissue and decrease fat deposition, whereas there are no data for immunocastrated boars. The aims of this investigation were 1) to assess whether the growth performance of all sexes could be maintained over 31 d by using a step-up dietary ractopamine feeding program of 5 mg/kg of ractopamine for the first 14 d, then increasing the dose to 10 mg/kg for a further 17 d, and 2) to determine if dietary ractopamine would increase lean mass in all sexes and decrease fat mass in boars and immunocastrated boars. The study involved 286 pigs randomized and proportionally allocated by breed into 24 groups of 11 or 12 pigs at 17 wk of age, with equal groups of boars, immunocastrated boars, and gilts. Dietary ractopamine decreased (P = 0.005) ADFI during the first 2 wk, particularly in the intact and immunocastrated boars, with the reduction in ADFI being maintained in the immunocastrated boars after the increment in dietary ractopamine. Daily BW gain was not altered by dietary ractopamine during the first 2 wk, but was increased (P < 0.001) after the increment in dietary ractopamine. Dietary ractopamine decreased (P < or = 0.033) feed conversion ratio in all sexes with the response being greater after the increase in dietary ractopamine. Carcass weight was increased (P < 0.001) by dietary ractopamine in all sexes, whereas back fat tended (P = 0.076) to be reduced in the immunocastrated boars. Dietary ractopamine increased (P = 0.018) lean tissue mass by 4.0, 4.8, and 6.5 kg in the intact boars, gilts, and immunocastrated boars, respectively. In the entire and immunocastrated boars, the increase in lean tissue was accompanied with a decrease (P = 0.004) in fat mass. There was little effect of dietary ractopamine on fat mass in gilts. However, carcass percent fat was decreased (P = 0.004) and percent lean increased (P = 0.006) in all sexes. Immunocastration caused a decrease in lean tissue mass and an increase in fat mass and an increase in ADFI in the last one-half of the study. Dietary ractopamine may decrease fat mass in intact and immunocastrated boars and offers an excellent means of maximizing the effects of immunocastration and minimizing the increase in fat mass sometimes observed in immunocastrated boars.

Dietary lupins (Lupinus angustifolius and Lupinus albus) can increase digesta retention in the gastrointestinal tract of pigs

Lupins are high in crude protein, cell wall materials, and gross energy but uncertainty about the bioavailability of nutrients and adverse effects on feed intake limit their use in the pig industry. Three experiments were conducted to determine the effect of lupins on retention time in the digestive tract by determining the average time it took for ingested polyethylene beads to pass through the digestive tract of pigs fed wheat-based diets containing various lupin species and fractions. In Expt 1, pigs were restrictively fed (1.8 kg/day) diets containing either predominantly wheat or predominantly wheat plus 400 g/kg peas or L. angustifolius seeds or kernels. The retention times of diets containing 400 g/kg of L. angustifolius seeds or kernels were significantly greater than those containing wheat alone (66.4 and 64.3 v. 48.8 h, P > 0.05, s.e.d. = 7.7 h), while that for the diet containing 400 g/ kg peas was intermediate (55.8 h). In Expt 2 and 3, pigs were fed 1 of 6 wheat-based diets balanced for digestible energy (DE) and amino acid composition and containing either animal protein or 350 g/kg of peas, and L. angustifolius seeds or kernels, or L. albus seeds and kernels. Pigs were restrictively fed (1.5 kg/day) for Expt 2 or fed ad libitum for Expt 3. The mean retention time of the L. albus diets was greater than the other diets in both experiments. Feed intake and daily gain were reduced in pigs fed diets containing L. albus. Despite having lower feed intakes, pigs fed diets containing L. albus had more digesta in the stomach and small intestine at slaughter than the pigs consuming the diets not containing lupins. Appropriate physical treatment or enzymatic supplementation of L. albus diets may alleviate some of the feed intake problems.

Assessment of apparent ileal digestibility of amino acids and nitrogen in cottonseed and soyabean meals fed to pigs determined using ileal dissection under halothane anaesthesia or following carbon dioxide stunning

Two experiments were conducted to determine apparent ileal digestibility of amino acids (AIDAA) and nitrogen (AIDN) in cottonseed meal (CSM) and soyabean meal (SBM) fed to growing pigs. In the first experiment, twenty-four male pigs (37.3 (SE 2.7) kg) were individually penned and randomized to either CSM or SBM diets. The diets contained 40% of the protein meal (either CSM or SBM) in a wheat starch-sucrose (1:1, w/w) base containing vitamins and minerals, and Cr2O3 as an indigestible marker. Pigs were acclimated to the experimental diets over a 3 d period and on day 4 through to day 14 were offered 1800 g/d of the diet. Diets were offered in three meals/d from day 4 to day 11 and in eight meals/d from day 12 to day 13. After the eighth hourly-meal on day 14, twelve pigs were anaesthetized with halothane while the remaining twelve pigs were CO2-stunned and processed using commercial slaughter procedures. Ileal digesta were collected from a 1500 mm portion of the terminal ileum of each pig and subsequently analysed for amino acids, N, organic matter and Cr. Results indicated that AIDAA of CSM and SBM were lower when digesta were collected following CO2-stunning than when digesta were obtained under halothane anaesthesia. Consistently, AIDN in CSM (0.51 v. 0.56) and SBM (0.55 v. 0.71) were lower (P < 0.05) in CO2-stunned pigs than in halothane-anaesthetized pigs. Furthermore, when digesta collection was conducted under halothane anaesthesia, AIDN of CSM was lower (P < 0.001) than that of SBM. In the second experiment, six male pigs (45 (SE 2.6) kg) were fitted with T-piece cannulas implanted in the terminal ileum, housed individually in metabolism cages, and randomly allocated to either CSM or SBM diets in a single reversal arrangement. Ileal digesta were collected for AIDAA and AIDN determination. Although statistical comparisons could not be made between the two experiments, the AIDAA and AIDN data obtained via cannulated pigs were similar to those values obtained using the halothane-anaesthesia method. Overall, the CO2-stunning method is not recommended for studies of amino acid or nitrogen ileal digestibilities, but may be useful for the study of other dietary constituents.

Dietary ractopamine promotes growth, feed efficiency and carcass responses over a wide range of available lysine levels in finisher boars and gilts

The aim of this study was to investigate the performance and carcass responses of finisher boars and gilts offered a range of dietary lysine levels and three levels of dietary ractopamine hydrochloride (RAC). The study involved three experiments of 90 pigs each, totalling 270 individually penned pigs in a 2 by 5 by 3 factorial design comprising two sexes (gilts, boars), five levels of dietary lysine [0.40, 0.48, 0.56, 0.64, and 0.72 g available lysine per MJ of of digestible energy (DE), respectively] and three RAC dose regimes (0, 5 and 10 mg/kg) for 28 days. An outbreak of pneumonia (Actinobaccilus pleuropneumonia) at Day 26 in Experiment 1 compromised Day 28 data; however, Day 21 data was considered suitable across all three experiments. The results indicate that 0.56 g available lysine/MJ DE is sufficient to maximise average daily gain (ADG), feed conversion ratio (FCR) and carcass weight in gilts. Control boars indicated that ADG and FCR were not limited by the lysine : energy ratios fed in this study. Increasing levels of dietary lysine linearly increased ADG (P < 0.001), improved FCR (P < 0.001) and increased carcass weight (P = 0.001). Likewise, increasing dietary RAC further improved ADG(P = 0.001), FCR (P = 0.002) and carcass weight (P = 0.075) linearly. The critical lysine levels calculated for ADG and FCR in gilts fed diets supplemented with RAC were less than required for controls. Boars had higher critical lysine levels than gilts when supplemented with dietary RAC, and increasing dietary RAC increased critical lysine levels for ADG and FCR in gilts and boars. An interaction (P = 0.016) between dietary lysine and RAC occurred for FCR, such that the response to 5 mg/kg dietary RAC diminished in diets containing 0.64 g and 0.72 g available lysine/MJ DE; however, these diets elicited a response when supplemented with 10 mg/kg RAC. Responses in ADG, FCR and carcass weight to dietary RAC were noted when dietary lysine was at or below the current recommendations for RAC diets, and it was suggested that this may have been due to reduced efficiency of lysine utilisation due to chronic disease challenge. A Sex X RAC interaction (P = 0.027) occurred for carcass P2, indicating the higher RAC dose reduced carcass P2 in boars but not in gilts. When formulating finisher pig diets between 60 and 90 kg liveweight, consideration of the lysine : energy requirements for boars and gilts is needed in order to maximise ADG, FCR and carcass characteristics. When supplementing pigs with dietary RAC, a wide range of lysine : energy levels maybe employed; however, this is dependent on RAC inclusion level and probably herd health.

Current recommended levels of dietary lysine in finisher pig diets are sufficient to maximise the response to ractopamine over 28 days but are insufficient in the first 7 days

Dietary ractopamine increases lean tissue deposition and responses increase as dose is increased provided sufficient dietary lysine is supplied. In Australia, diets supplemented with ractopamine (RAC) are formulated with 0.56 g available lysine per MJ digestible energy. The present study was conducted to investigate the interactions between dietary RAC and lysine on growth and carcass characteristics in ad libitum fed (13.8 MJ/kg) boars and gilts. The study involved 108 individually penned pigs at 17 weeks of age (64.1 ± 0.57 kg) in a 2 by 2 by 3 factorial design, with the respective factors being sex (gilt or boar), dietary lysine (low and high, i.e. 0.56 or 0.65 g available lysine/MJ digestible energy, respectively) and dietary RAC (0, 5 or 20 mg/kg) for 28 days. Over the 28-day study duration, both lysine diets containing dietary RAC were sufficient to elicit a response in average daily gain (ADG) (+5.8%, P = 0.026) and carcass weight (3%, P = 0.045), but not in feed efficiency (FE) (P = 0.555). However, over the period of the first 7 days, there were interactions between the effects of RAC and lysine for FE (P = 0.025) and ADG (P = 0.023), with both traits being responsive only to dietary RAC containing the high lysine, which increased FE (+9.1%, P = 0.002) and ADG (+7.2%, P = 0.068). Dietary RAC improved FE in the latter stages of the study, namely Days 15–21 (+5.7%, P = 0.031) and Days 22–28 (+4.9%, P = 0.040). The high RAC diet reduced carcass P2 backfat (–16.5%, P < 0.001) and fat tissue deposition (–6.2%, P = 0.074) and high lysine tended to reduce fat tissue deposition (–13.3%, P = 0.072). A sex by lysine interaction (P = 0.043) was observed for lean tissue deposition at 28 days, such that only the high-lysine diet increased lean deposition in boars (+11%, P < 0.05) but not in gilts. Dietary RAC tended to increase lean deposition (+14.0%, P = 0.067) in the first 14 days; however, only the high RAC diet increased lean deposition (+9.6%, P < 0.05) over 28 days. In conclusion, the current recommended supplementation levels of lysine for commercial gilts and boars fed RAC may limit the response to dietary RAC if the feeding regime is for short durations and boars will not maximise their lean tissue deposition rates.